Pear Therapeutics, Inc. Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q1 2021 to Q1 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Pear Therapeutics, Inc. annual/quarterly Net Cash Provided by (Used in) Financing Activities history and growth rate from Q1 2021 to Q1 2022.
  • Pear Therapeutics, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2022 was $75K, a 99.6% decline year-over-year.
  • Pear Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $2.16M, a 98.7% decline from 2021.
  • Pear Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $164M, a 78.9% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2022 $75K -$20.2M -99.6% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-16
Q1 2021 $20.3M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.